{
    "clinical_study": {
        "@rank": "139771", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      I. Define the growth rates and clinical course of NF2-related tumors in patients with\n      neurofibromatosis type 2. Associate growth rate with physical function."
        }, 
        "brief_title": "NF2 Natural History Consortium", 
        "condition": [
            "Schwannoma, Vestibular", 
            "Neurofibromatosis 2", 
            "Meningioma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Meningioma", 
                "Neurilemmoma", 
                "Neurofibromatoses", 
                "Neurofibromatosis 1", 
                "Neurofibromatosis 2", 
                "Neuroma, Acoustic"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: Data on the clinical course and growth rate of NF2-related tumors in\n      patients with neurofibromatosis 2. Patients are evaluated each year on a cranial and a\n      spinal MRI, eye tests, hearing tests, quality of life, neurological tests, and physical\n      functioning."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics--\n\n          -  Diagnosed with neurofibromatosis 2 on or after 01/01/93\n\n          -  Must meet one of the following conditions:\n\n        Bilateral vestibular schwannoma OR Family history of neurofibromatosis 2 (first degree\n        family relative) AND Unilateral vestibular schwannoma at under 30 years OR Any 2 of the\n        following: Meningioma Glioma Schwannoma Juvenile posterior subcapsular lenticular\n        opacity/juvenile cortical cataract\n\n          -  No plans to treat vestibular schwannoma in next 12 months\n\n        --Prior/Concurrent Therapy--\n\n          -  Not specified\n\n        --Patient Characteristics--\n\n          -  Age: 5 and over"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "5 Years"
        }, 
        "enrollment": "100", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004483", 
            "org_study_id": "199/14226", 
            "secondary_id": [
                "HEI-NF2", 
                "HEI-DAMD17-01-1-0710"
            ]
        }, 
        "lastchanged_date": "September 27, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90057-9927"
                }, 
                "name": "House Ear Institute"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "overall_official": {
            "affiliation": "House Ear Institute", 
            "last_name": "William H. Slattery, III", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Unspecified"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "citation": "Masuda, Ann. Slattery, William H. III, Fisher, Laurel M., Oppenheimer, Mark. Audiological Characteristics of Initial Presentation of NF2 Patients: Preliminary Results. Abstract submitted to: Combined Otolaryngological Spring Meetings (COSM)."
            }, 
            {
                "citation": "Fisher, Laurel M., Slattery, WIlliam H. III, Yoon, Gloria. MRI Test-Retest Study of NF2 Patients. Abstract Submitted to: Combined Otolaryngological Spring Meetings (COSM)."
            }, 
            {
                "PMID": "15021775", 
                "citation": "Masuda A, Fisher LM, Oppenheimer ML, Iqbal Z, Slattery WH; Natural History Consortium. Hearing changes after diagnosis in neurofibromatosis type 2. Otol Neurotol. 2004 Mar;25(2):150-4."
            }, 
            {
                "PMID": "16015177", 
                "citation": "Slattery WH, Lev MH, Fisher LM, Connell SS, Iqbal Z, Go JL; NF2 Natural History Consortium. MRI evaluation of neurofibromatosis 2 patients: a standardized approach for accuracy in interpretation. Otol Neurotol. 2005 Jul;26(4):733-40."
            }, 
            {
                "PMID": "15354016", 
                "citation": "Slattery WH 3rd, Fisher LM, Iqbal Z, Oppenhiemer M. Vestibular schwannoma growth rates in neurofibromatosis type 2 natural history consortium subjects. Otol Neurotol. 2004 Sep;25(5):811-7."
            }, 
            {
                "citation": "Zacharia, T., Lev, M., Iqbal, Z.T., Fisher ,L.M. , Gupta, MS, Slattery, WH. (2003) Intramedullary Spinal Tumors In NF II: Incidence And Imaging Characteristics American Radiology Society, 2003."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004483"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "House Ear Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2002", 
        "study_design": "Observational Model: Natural History, Time Perspective: Longitudinal", 
        "study_type": "Observational", 
        "verification_date": "September 2005"
    }, 
    "geocoordinates": {
        "House Ear Institute": "34.052 -118.244"
    }
}